Literature DB >> 2545049

[Stereotaxic biopsy of intracranial processes: validity of histologic diagnosis].

K Ungersböck1, M Schmidbauer, H Budka, K Kitz, P Grunert, W Koos.   

Abstract

The diagnostic validity of stereotactic intracranial biopsies was investigated in 70 patients retrospectively. In 56 cases (80%) the presence of a neoplastic lesion as well as its grade of malignancy was proved by cytological, histological and immunohistochemical techniques. An inflammatory or vascular lesion was found in 8 patients (11.4%). In 6 patients (8.6%) the nature of the lesion remained unclear because of nonspecific histological findings. In 27 cases a correlation was found between the biopsy specimens and corresponding material obtained during open surgery or autopsy. 24 concordant results were found (88.9%). In one case a malignant tumour was classified only according to the findings obtained at operation. In two cases subsequently diagnosed as glioblastoma biopsy reported a higher differentiated astrocytoma and a non-neoplastic lesion, respectively. These results confirm stereotactic biopsy of intracranial lesions as a method with low complication rate and high diagnostic validity.

Entities:  

Mesh:

Year:  1989        PMID: 2545049

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  3 in total

1.  CT-guided and computer assisted stereotactic biopsy. Technique, results, indications.

Authors:  J Voges; R Schröder; H Treuer; O Pastyr; W Schlegel; W J Lorenz; V Sturm
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

2.  Results of 200 intracranial stereotactic biopsies.

Authors:  P Grunert; K Ungersböck; J Bohl; K Kitz; N Hopf
Journal:  Neurosurg Rev       Date:  1994       Impact factor: 3.042

3.  Stereotactic techniques in managing pediatric brain tumors.

Authors:  P M Black; N J Tarbell; E Alexander; M Rockoff; M S Zhan; J Loeffler
Journal:  Childs Nerv Syst       Date:  1993-09       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.